新冠病毒感染患者血流感染的患病率及其病因：双城故事
Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients: A Tale of Two Cities.
作者信息
Tyagi Niraj
机构信息
Institute of Critical Care and Emergency Medicine, Sir Ganga Ram Hospital, New Delhi, India.
出版信息
Indian J Crit Care Med. 2021 Apr;25(4):355-357. doi: 10.5005/jp-journals-10071-23797.
Abstract
Tyagi N. Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients: A Tale of Two Cities. Indian J Crit Care Med 2021;25(4):355-357.
摘要
蒂亚吉·N。新冠病毒感染患者血流感染的患病率及其病因：双城故事。《印度重症监护医学杂志》2021年；25(4)：355 - 357。
相似文献
1
Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients: A Tale of Two Cities.新冠病毒感染患者血流感染的患病率及其病因：双城故事
Indian J Crit Care Med. 2021 Apr;25(4):355-357. doi: 10.5005/jp-journals-10071-23797.
2
Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients Admitted in a Tertiary Care Hospital in Jaipur.斋浦尔一家三级护理医院收治的新冠肺炎患者血流感染的患病率及其病因
Indian J Crit Care Med. 2021 Apr;25(4):369-373. doi: 10.5005/jp-journals-10071-23781.
3
Acute Flaccid Quadriparesis in a Recovering COVID-19 Patient: A Clinical Dilemma.一名正在康复的新冠肺炎患者出现急性弛缓性四肢瘫：临床难题
Indian J Crit Care Med. 2021 Feb;25(2):238-239. doi: 10.5005/jp-journals-10071-23728.
4
Transport Circuit during COVID-19 Crisis: A Simple Modification of the Bain's Circuit for Safety of Healthcare Workers.新冠疫情危机期间的转运回路：对贝恩回路的简单改良以保障医护人员安全
Indian J Crit Care Med. 2020 Dec;24(12):1281-1283. doi: 10.5005/jp-journals-10071-23686.
5
Toxicoepidemiology of Acute Poisoning: A Classic Tale of Two Indias.急性中毒的毒理流行病学：两个印度的经典故事
Indian J Crit Care Med. 2024 Apr;28(4):364-368. doi: 10.5005/jp-journals-10071-24692.
6
Critically Ill Obstetric Patients: Much more than Meets the Eye.危重症产科患者：远非表面所见那么简单。
Indian J Crit Care Med. 2019 Oct;23(10):493. doi: 10.5005/jp-journals-10071-23274.
7
ABG Analyzer for Electrolyte Measurement in ICU Patients: To Do or Not to Do.用于ICU患者电解质测量的动脉血气分析仪：做还是不做。
Indian J Crit Care Med. 2024 May;28(5):416-418. doi: 10.5005/jp-journals-10071-24722.
8
Where Has All the "HES" Gone: A Case in Point vs "Crusade" to Obscurity.所有的“羟乙基淀粉”都去哪儿了：一个与“走向默默无闻”的“讨伐”相关的例证
Indian J Crit Care Med. 2020 Nov;24(11):1012-1013. doi: 10.5005/jp-journals-10071-23654.
9
Spontaneous Air-leak Syndrome and COVID-19: A Multifaceted Challenge.自发性气胸综合征与2019冠状病毒病：一个多方面的挑战
Indian J Crit Care Med. 2021 May;25(5):584-587. doi: 10.5005/jp-journals-10071-23819.
10
Critical Care for COVID-19 Affected Patients: Position Statement of the Indian Society of Critical Care Medicine.新型冠状病毒肺炎（COVID-19）感染患者的重症监护：印度重症监护医学学会立场声明
Indian J Crit Care Med. 2020 Apr;24(4):222-241. doi: 10.5005/jp-journals-10071-23395.
引用本文的文献
1
Comparative Study Between the First and Second Wave of COVID-19 Deaths in India: A Single Center Study.印度新冠疫情第一波与第二波死亡病例的对比研究：一项单中心研究
Cureus. 2023 Apr 12;15(4):e37472. doi: 10.7759/cureus.37472. eCollection 2023 Apr.
本文引用的文献
1
Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients Admitted in a Tertiary Care Hospital in Jaipur.斋浦尔一家三级护理医院收治的新冠肺炎患者血流感染的患病率及其病因
Indian J Crit Care Med. 2021 Apr;25(4):369-373. doi: 10.5005/jp-journals-10071-23781.
2
Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance.在一家印度三级护理医院的专门 COVID-19 病房中 COVID-19 患者的合并感染和继发感染情况简介：对抗菌药物耐药性的影响。
Indian J Med Microbiol. 2021 Apr;39(2):147-153. doi: 10.1016/j.ijmmb.2020.10.014. Epub 2020 Nov 2.
3
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.COVID-19 住院患者的继发感染：发生率和预测因素。
Clin Microbiol Infect. 2021 Mar;27(3):451-457. doi: 10.1016/j.cmi.2020.10.021. Epub 2020 Oct 24.
4
Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.中国武汉 COVID-19 住院患者继发细菌性感染的病因和抗菌药物耐药性：一项回顾性分析。
Antimicrob Resist Infect Control. 2020 Sep 22;9(1):153. doi: 10.1186/s13756-020-00819-1.
5
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染：一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
6
Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City.纽约市新冠疫情高峰期的菌血症与血培养利用情况
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00875-20.
7
COVID-19 associated pulmonary aspergillosis.COVID-19 相关肺曲霉病。
Mycoses. 2020 Jun;63(6):528-534. doi: 10.1111/myc.13096. Epub 2020 May 15.
8
COVID-19 with Different Severities: A Multicenter Study of Clinical Features.不同严重程度的 COVID-19：一项多中心临床特征研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.炎症性关节炎治疗患者的感染风险：非生物制剂与生物制剂。
Expert Rev Clin Immunol. 2020 Feb;16(2):207-228. doi: 10.1080/1744666X.2019.1705785. Epub 2020 Jan 11.
Zotero 插件